New vaccine strategy may fight genital herpes, mouse study suggests

October 17, 2012
New vaccine strategy may fight genital herpes, mouse study suggests
Approach may also protect against other sexually transmitted infections, researchers say.

(HealthDay)—A new vaccination approach may provide protection against genital herpes as well as other sexually transmitted infections, including HIV, according to a new study involving mice.

The vaccination model developed by researchers at Yale University focuses on tissue in the vagina where viral exposure occurs, rather than the immune system's antibodies, known as T-cells, which circulate throughout the body.

In conducting the study, the researchers recruited T cells to vaginal tissue using what they called a "prime and pull" strategy. They first primed the mice's immune systems by triggering a system-wide T-cell response. Then, they recruited activated T cells to vaginal tissue by topically applying chemokines, substances that help mobilize .

The researchers said the strategy could offer protection against genital herpes, caused by the , by limiting it's spread into the . They noted this vaccination model may also protect against other sexually transmitted infections, such as HIV-1.

"This new vaccine approach can work with any vaccines that elicit strong T-, and will set the stage for protection against infectious diseases by setting up memory T-cells at the site of exposure," study lead author Akiko Iwasaki, professor of immunobiology at Yale School of Medicine and a member of Yale Cancer Center's program, explained in a university news release.

"This technology can be potentially applied to other infectious agents that enter through a given portal, such as the genital tract, respiratory tract, the skin, or gut," Iwasaki added.

The researchers noted that is the most commonly sexually transmitted infection. Currently, there is no cure for the condition.

The study was published online Oct. 17 in Nature.

Experts note that results from animal research, while sometimes promising, are not always replicated in humans.

Explore further: Sexually transmitted co-infections increase HIV risk: study

More information: DOI: 10.1038/nature11522

Related Stories

Sexually transmitted co-infections increase HIV risk: study

June 20, 2011
(Medical Xpress) -- Bacterial and viral sexually transmitted infections can exacerbate HIV replication in co- infected individuals, a team of Canadian researchers led by Charu Kaushic, associate professor of pathology and ...

Recurring genital problems could be herpes

April 11, 2011
A study of patients attending sexual health clinics in Gothenburg found that just four out of ten patients with genital herpes actually knew that they had the disorder. However, a third of those who did not realise that they ...

Research shows progress toward a genital herpes vaccine

January 4, 2012
An investigational vaccine protected some women against infection from one of the two types of herpes simplex viruses that cause genital herpes, according to findings in the New England Journal of Medicine.

Genital herpes more virulent in Africa than in US

April 15, 2011
Strains of genital herpes in Africa are far more virulent than those in the United States, researchers at Harvard Medical School report, a striking insight into a common disease with important implications for preventing ...

Recommended for you

Protein Daple coordinates single-cell and organ-wide directionality in the inner ear

December 11, 2017
Humans inherited the capacity to hear sounds thanks to structures that evolved millions of years ago. Sensory "hair cells" in the inner ear have the amazing ability to convert sound waves into electrical signals and transmit ...

Team identifies DNA element that may cause rare movement disorder

December 11, 2017
A team of Massachusetts General Hospital (MGH) researchers has identified a specific genetic change that may be the cause of a rare but severe neurological disorder called X-linked dystonia parkinsonism (XDP). Occurring only ...

Gene therapy improves immunity in babies with 'bubble boy' disease

December 9, 2017
Early evidence suggests that gene therapy developed at St. Jude Children's Research Hospital will lead to broad protection for infants with the devastating immune disorder X-linked severe combined immunodeficiency disorder. ...

In lab research, scientists slow progression of a fatal form of muscular dystrophy

December 8, 2017
In a paper published in the Nature journal Scientific Reports, Saint Louis University (SLU) researchers report that a new drug reduces fibrosis (scarring) and prevents loss of muscle function in an animal model of Duchenne ...

Double-blind study shows HIV vaccine not effective in viral suppression

December 7, 2017
(Medical Xpress)—A large team of researchers from the U.S. and Canada has conducted a randomized double-blind study of the effectiveness of an HIV vaccine and has found it to be ineffective in suppressing the virus. In ...

Time matters: Does our biological clock keep cancer at bay?

December 7, 2017
Our body has an internal biological or "circadian" clock, which cycles daily and is synchronized with solar time. New research done in mice suggests that it can help suppress cancer. The study, publishing 7 December in the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.